The immunological hallmark of SLE is ANA positivity, which is primarily used for screening purposes, and the pattern of autoantibodies expressed by individuals with this prototypic autoimmune disease is highly distinctive [26,27]. The gene discussed is BTG3; the disease is systemic lupus erythematosus.